Prothena to Report Second Quarter 2026 Financial Results on August 6 July 30, 2026 Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its second quarter and first six months of 2026 financial results on Thursday, August 6, 2026, after the close of the U.S. financial markets. Consistent with past practice, [...]
Reply S.p.A: The Board of Directors Approves the Half-year Financial Report as of 30 June 2026 July 30, 2026 All economic and financial indicators grew: Consolidated turnover of €1,311.9 million (1,221.3 in H1 2025); EBITDA of €233.2 million (223.7 in H1 2025); EBIT a of €189.7 million (188.4 in H1 2025); Pre-tax profit of €194.1 million (179.4 in H1 2025).
De’ Longhi Group: a Quarter of Robust Revenue Growth of 8.4% and Solid Margin Expansion Drives an Upward Guidance Revision July 30, 2026 Substantial expansion in Professional and acceleration in Household drive growth and margins, enabling further investments in marketing and product innovation as part of the Group's continuous strategic evolution
Titan Group: First Half 2026 Results July 30, 2026 Strong sales performance with continued margin expansion, while accelerating the integration of new acquisitions
Fluidra Delivers a Strong First Half of 2026 and Maintains Positive Momentum in a Dynamic Environment July 30, 2026 Sales increased by 5% at constant FX to €1,258 million, driven by Fluidra’s customer focus and consistent execution Adjusted EBITDA grew by 6% at constant FX to €321 million, supported by firm cost discipline The company signed an agreement to acquire Hydrapro, a French manufacturer specializing in water treatment, to further support its growth Fluidra launches a €40 million share buy-back program and maintains full-year guidance
SES Reports H1 2026 Results & Reiterates Full-Year Outlook July 30, 2026 SES S.A. announces financial results for the three and six months ended June 30, 2026. H1 2026 Performance (€ million) H1 2026 as reported (1) H1 2025 as reported (1) ∆ At constant FX (2) H1 2025 like-for-like(3) ∆ At constant FX (2) Average €/$ FX rate 1.17 1.08 1.08 Revenue 1,602 978 [...]
AB InBev Reports Second Quarter 2026 Results July 30, 2026 Solid top- and bottom-line performance: Revenue up by 5.6%, Beer volume growth of 1.1% and a 23.4% Underlying EPS increase
Everest Reports Second Quarter 2026 Results July 29, 2026 Annualized 14.2% Net Income ROE and 14.9% Net Operating Income ROE Annualized Total Shareholder Return of 16.8% $559 million of Net Income and Combined Ratio of 92.0% $317 million of Underwriting Income and Combined Ratio of 90.0% from our Core Businesses* Repurchased $395 million of Common Shares During the Quarter
Arm Holdings plc Reports Results for the First Quarter of the Fiscal Year Ending 2027 July 29, 2026 Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has today published a letter to its shareholders containing the company’s results for its first quarter of fiscal year 2027, which ended June 30, 2026. The letter is available on its investor relations website (https://investors.arm.com/financials/quarterly-annual-results). The shareholder letter will also be [...]
Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026 July 29, 2026 Compass Management will host a conference call at 8:00 am ET (1:00 pm UK)